STUDY PROTOCOL
Published on 07 Aug 2025
Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design
doi 10.3389/fphar.2025.1618987
- 415 views